This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Synapse B.v.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Raed Al-Dieri: Innovator in Thrombin Activity Measurement
Introduction: Raed Al-Dieri, an inventive mind based in Maastricht, Netherlands, has made significant strides in the medical field with his innovative approach to measuring thrombin activity. With a keen focus on enhancing diagnostic methods, his work aims to improve healthcare outcomes through advanced technology.
Latest Patents: Al-Dieri holds a patent for his groundbreaking invention titled "Measuring thrombin activity in whole blood." This invention outlines a method for in vitro determination of thrombin activity in blood samples. The process includes contacting a blood sample with a fluorogenic substrate of thrombin, allowing thrombin generation, and then measuring the resulting fluorescence emitted from the sample. This innovative technique promises to offer precise measurements crucial for various clinical applications.
Career Highlights: Currently, Raed Al-Dieri is associated with Synapse B.V., where he applies his expertise in the biomedical field to further develop diagnostic technologies. His contributions to medical innovation are underscored by his dedication to enhancing blood coagulation assessments, which are vital for patient management in numerous healthcare settings.
Collaborations: Throughout his career, Al-Dieri has collaborated with notable peers, including Hendrik Coenraad Hemker and Suzette L. Beguin. Together, they have contributed to the advancement of research and technology in hematology, fostering an environment of innovation and scientific inquiry.
Conclusion: Raed Al-Dieri is a prominent figure in the realm of medical innovations, particularly in the field of thrombin measurement. His contributions through patents and collaborative efforts continue to pave the way for advancements that can significantly impact patient diagnostics and treatment in medicine. As he continues his work at Synapse B.V., the medical community looks forward to his future innovations that hold the potential to revolutionize healthcare practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile